Article 58 / Inclusion of substances in Annex XIV
Article 58
Inclusion of substances in Annex XIV
Whenever a decision is taken to include in Annex XIV substances referred to in Article 57, such a decision shall be taken in accordance with the procedure referred to in Article 133(4). It shall specify for each substance:
the identity of the substance as specified in Section 2 of Annex VI;
the intrinsic property (properties) of the substance referred to in Article 57;
transitional arrangements:
the date(s) from which the placing on the market and the use of the substance shall be prohibited unless an authorisation is granted (hereinafter referred to as the sunset date) which should take into account, where appropriate, the production cycle specified for that use;
a date or dates at least 18 months before the sunset date(s) by which applications must be received if the applicant wishes to continue to use the substance or place it on the market for certain uses after the sunset date(s); these continued uses shall be allowed after the sunset date until a decision on the application for authorisation is taken;
review periods for certain uses, if appropriate;
uses or categories of uses exempted from the authorisation requirement, if any, and conditions for such exemptions, if any.
Prior to a decision to include substances in Annex XIV, the Agency shall, taking into account the opinion of the Member State Committee, recommend priority substances to be included specifying for each substance the items set out in paragraph 1. Priority shall normally be given to substances with:
PBT or vPvB properties; or
wide dispersive use; or
high volumes.
The number of substances included in Annex XIV and the dates specified under paragraph 1 shall also take account of the Agency's capacity to handle applications in the time provided for. The Agency shall make its first recommendation of priority substances to be included in Annex XIV by 1 June 2009. The Agency shall make further recommendations at least every second year with a view to including further substances in Annex XIV.
The Agency shall update its recommendation, taking into account the comments received.